The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II study of cabozantinib and nivolumab in refractory metastatic microsatellite stable (MSS) colorectal cancer (CRC).
 
Alexis Leal
Employment - Elsevier
Leadership - Elsevier
Honoraria - MedPro Specialty Advisory Board
Research Funding - Abbvie (Inst); Antengene (Inst); Arrys Therapeutics (Inst); Bristol-Myers Squibb (Inst); Conjupro Biotherapeutics (Inst); Corcept Therapeutics (Inst); Elicio Therapeutics (Inst); Exelixis (Inst); FameWave Ltd. (Inst); Hutchison MediPharma (Inst); Takeda (Inst)
 
Patrick Blatchford
Employment - BioMimetix; Clovis Oncology; Criterium; Worldwide Clinical Trials Holdings, Inc.
Consulting or Advisory Role - BioMimetix; Clovis Oncology; Criterium; Worldwide Clinical Trials
 
Sunnie Kim
Honoraria - Merck
Consulting or Advisory Role - Astellas Pharma; Daiichi Sankyo/Lilly; I-Mab
Research Funding - Merck
 
Robert Lentz
Consulting or Advisory Role - Agenus (Inst); Boehringer Ingelheim (Inst); Merck (Inst); Natera (Inst)
Research Funding - ALX Oncology (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Experimental Drug Development Centre (EDDC)/A*STAR (Inst); Guardant Health (Inst); Lilly (Inst); Merck (Inst)
 
Douglas Kemme
No Relationships to Disclose
 
McKenna Russen
No Relationships to Disclose
 
Tyler Friedrich
No Relationships to Disclose
 
Lynn Mathew
No Relationships to Disclose
 
Robert Hoyer
No Relationships to Disclose
 
Scott Kono
No Relationships to Disclose
 
Emily Baiyee Toegel
No Relationships to Disclose
 
Stacey Bagby
No Relationships to Disclose
 
Adrian Dominguez
No Relationships to Disclose
 
S. Lindsey Davis
Stock and Other Ownership Interests - Johnson & Johnson/MedTech
Speakers' Bureau - Allergan (I)
Research Funding - Bristol-Myers Squibb (Inst); EMD Serono (Inst); I-Mab (Inst); Merck (Inst); ORIC Pharmaceuticals (Inst); Seagen (Inst); Symphogen (Inst); TriSalus Life Sciences (Inst); Tvardi Therapeutics (Inst)
 
Todd Pitts
Research Funding - ALX Oncology; AstraZeneca; Exelixis; Takeda
 
Christopher Lieu
Consulting or Advisory Role - Amgen (Inst)
Research Funding - Genentech (Inst)
 
Wells Messersmith
Honoraria - Research to Practice (Inst)
Consulting or Advisory Role - Amgen; Criterium (Inst)
Research Funding - Agenus (Inst); ALX Oncology (Inst); AstraZeneca/MedImmune (I); Beigene (Inst); CanBas (Inst); Exelixis (Inst); Experimental Drug Development Centre (EDDC); FATE Therapeutics (Inst); Mirati Therapeutics (Inst); Nurix (Inst); Pfizer (Inst); PureTech (Inst); RasCal (Inst); Revolution Medicines (Inst)